Journal
ANTI-CANCER DRUGS
Volume 15, Issue 4, Pages 303-309Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001813-200404000-00001
Keywords
beta-adrenoceptor antagonist antioxidant; carvedilol; CYP3A4; MDR1/P-glycoprotein; multidrug resistance
Categories
Ask authors/readers for more resources
In 1983, carvedilol [1-[carbazolyl-(4)-oxy]-3-[(2-methoxyphenoxyethyl)amino]-2-propanol] was designed and developed as a beta-adrenoceptor antagonist with vasodilating activity for efficacious and safe treatment of hypertension and coronary artery disease. Carvedilol belongs to the 'third generation' of beta-adrenoceptor antagonists and shows selectivity for the beta(1)- rather than beta(2)-adrenoceptor. Carvedilol is also an alpha(1)-blocking agents, with around 2- to 3-fold more selectivity for beta(1)- than alpha(1)-adrenoceptors. This degree of alpha(1)-blockade is responsible for the moderate vasodilator properties of carvedilol, being different from other beta-adrenoceptor antagonists. In addition, carvedilol is a potent antioxidant, with a 10-fold greater activity than vitamin E. Some carvedilol metabolites found in human plasma also exhibit antioxidative activity approximately 50- to 100-fold greater than carvedilol and other antioxidants. These unique properties of carvedilol, i.e. adrenergic (beta(1), beta(2) and alpha(1)) blockade and antioxidative activity, may be important in preventing progressive deterioration of left ventricular dysfunction and chronic heart failure. Recently, carvedilol has been demonstrated to reverse multidrug resistance (MDR) to anticancer drugs in tumor cells in vitro and its reversal effects were comparable with verapamil, which has been used in the first clinical trial for the reversal of MDR. This review introduces the reversal activity and usefulness against MDR, as well as an overview of the pharmacological and pharmacokinetic properties, of carvedilol. (C) 2004 Lippincott Williams Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available